Medical News

PL_preklad_studium_studie_vyzkum_data_zprava

How did alemtuzumab fare in real clinical practice?

11. 6. 2021 Source: Multiple Sclerosis

A study published by authors from the University of Massachusetts in January this year in the journal Multiple Sclerosis and Related Disorders focused on the effectiveness and safety of alemtuzumab. How did it fare in real clinical practice?

Reduction of LDL Cholesterol in the Prevention of Cardiovascular Morbidity and Mortality –⁠ Results of a Large Meta-Analysis

Elevated LDL cholesterol (LDL-c) is one of the main causes of atherosclerosis. The meta-analysis presented below examined the effect of reducing its levels on the risk of cardiovascular (CV)…

11. 6. 2021 Source: Chronic Heart Failure and Lipidology

Does Peritoneal Dialysis Have Its Place Even in Acute Cases?

In patients who urgently need to replace kidney function, hemodialysis traditionally played the role of the gold standard. Can peritoneal dialysis fully replace it?

8. 6. 2021 Source: Chronic Kidney Disease

Safety of Urgent Initiation of Peritoneal Dialysis

In case of urgent need for kidney function replacement, hemodialysis (HD) with a temporary venous catheter has long been the standard solution. However, it has several disadvantages such as increased…

8. 6. 2021 Source: Chronic Kidney Disease

Importance of Home Parenteral Therapy: ESPEN Recommendations from 2020

Home parenteral therapy currently plays a crucial role in the treatment and prevention of malnutrition in specific patient groups. The European Society for Clinical Nutrition and Metabolism (ESPEN)…

7. 6. 2021 Source: Parenteral Nutrition

Vitamins in Prevention and Treatment of COVID-19

Vitamin supplementation is an important part of therapy for various diseases, and it seems that they also play a significant role in the case of COVID-19. What kind of role? It's certainly not a…

7. 6. 2021 Source: Parenteral Nutrition

Current Results of Brigatinib in the Treatment of Lung Cancer

The results of the primary analysis showed a significant extension of PFS in patients with non-small cell lung cancer (NSCLC) treated with brigatinib compared to crizotinib. The recently published…

4. 6. 2021 Source: Non-Small Cell Lung Cancer

Position of the Aclidinium-Bromide/Formoterol-Fumarate Combination in COPD Treatment According to Current Recommendations

Dual bronchodilator therapy, which combines long-acting muscarinic antagonists (LAMA) and long-acting β-agonists (LABA), has become an integral part of the treatment for chronic obstructive pulmonary…

3. 6. 2021 Source: Treatment of Asthma and COPD

Fixed combination tiotropium/olodaterol in regular clinical practice: What do patients say?

A non-interventional international study assessed the therapeutic benefits of the fixed combination of tiotropium/olodaterol in the treatment of chronic obstructive pulmonary disease (COPD) in…

28. 5. 2021 Source: COPD

Silueta_lékaře_infuze_nemocniční_koridor_chodba_nemocnice

Thromboprophylaxis as a Common Part of Care for At-Risk Patients Requiring Hospitalization: Yes or No?

The proportion of patients requiring hospitalization who are at high risk of developing thromboembolic disease is relatively high. However, not all of these patients have this risk identified and…

28. 5. 2021 Source: Thromboprophylaxis

1 … 105 106 107 108 109 … 164

Back Filter by speciality

Remove filters